ARIZONA SONORAN COPPER CO IN (ASCU.CA) Fundamental Analysis & Valuation

TSX:ASCU • CA04058Q1054

Current stock price

7.93 CAD
-0.27 (-3.29%)
Last:

This ASCU.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. ASCU.CA Profitability Analysis

1.1 Basic Checks

  • ASCU had negative earnings in the past year.
  • ASCU had a positive operating cash flow in the past year.
  • ASCU had negative earnings in each of the past 5 years.
  • In the past 5 years ASCU reported 4 times negative operating cash flow.
ASCU.CA Yearly Net Income VS EBIT VS OCF VS FCFASCU.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 -10M -20M -30M -40M

1.2 Ratios

  • ASCU has a better Return On Assets (-1.34%) than 81.90% of its industry peers.
  • The Return On Equity of ASCU (-2.07%) is better than 81.40% of its industry peers.
Industry RankSector Rank
ROA -1.34%
ROE -2.07%
ROIC N/A
ROA(3y)-4.35%
ROA(5y)-9.46%
ROE(3y)-5.86%
ROE(5y)-11.6%
ROIC(3y)N/A
ROIC(5y)N/A
ASCU.CA Yearly ROA, ROE, ROICASCU.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ASCU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ASCU.CA Yearly Profit, Operating, Gross MarginsASCU.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025

5

2. ASCU.CA Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, ASCU has more shares outstanding
  • Compared to 5 years ago, ASCU has more shares outstanding
  • ASCU has a better debt/assets ratio than last year.
ASCU.CA Yearly Shares OutstandingASCU.CA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
ASCU.CA Yearly Total Debt VS Total AssetsASCU.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • An Altman-Z score of 5.96 indicates that ASCU is not in any danger for bankruptcy at the moment.
  • ASCU has a Altman-Z score of 5.96. This is comparable to the rest of the industry: ASCU outperforms 55.56% of its industry peers.
  • A Debt/Equity ratio of 0.03 indicates that ASCU is not too dependend on debt financing.
  • ASCU has a Debt to Equity ratio (0.03) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 5.96
ROIC/WACCN/A
WACCN/A
ASCU.CA Yearly LT Debt VS Equity VS FCFASCU.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M

2.3 Liquidity

  • A Current Ratio of 3.90 indicates that ASCU has no problem at all paying its short term obligations.
  • The Current ratio of ASCU (3.90) is better than 64.17% of its industry peers.
  • A Quick Ratio of 3.90 indicates that ASCU has no problem at all paying its short term obligations.
  • With a decent Quick ratio value of 3.90, ASCU is doing good in the industry, outperforming 64.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.9
Quick Ratio 3.9
ASCU.CA Yearly Current Assets VS Current LiabilitesASCU.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

0

3. ASCU.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 33.33% over the past year.
EPS 1Y (TTM)33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, ASCU will show a very negative growth in Earnings Per Share. The EPS will decrease by -44.84% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-2%
EPS Next 2Y-135.05%
EPS Next 3Y-69.21%
EPS Next 5Y-44.84%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ASCU.CA Yearly Revenue VS EstimatesASCU.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2029 2030 2031 2032 200M 400M 600M 800M 1B
ASCU.CA Yearly EPS VS EstimatesASCU.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.2 -0.2 0.4 0.6 0.8 1

0

4. ASCU.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • ASCU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year ASCU is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ASCU.CA Price Earnings VS Forward Price EarningsASCU.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100 -150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ASCU.CA Per share dataASCU.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

  • ASCU's earnings are expected to decrease with -69.21% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-135.05%
EPS Next 3Y-69.21%

0

5. ASCU.CA Dividend Analysis

5.1 Amount

  • ASCU does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ASCU.CA Fundamentals: All Metrics, Ratios and Statistics

ARIZONA SONORAN COPPER CO IN

TSX:ASCU (4/23/2026, 7:00:00 PM)

7.93

-0.27 (-3.29%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)03-30
Earnings (Next)05-13
Inst Owners35.75%
Inst Owner ChangeN/A
Ins Owners0.91%
Ins Owner ChangeN/A
Market Cap1.65B
Revenue(TTM)N/A
Net Income(TTM)-4.67M
Analysts81.33
Price Target8.15 (2.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.96%
Min EPS beat(2)1.96%
Max EPS beat(2)1.96%
EPS beat(4)4
Avg EPS beat(4)26.47%
Min EPS beat(4)1.96%
Max EPS beat(4)100%
EPS beat(8)6
Avg EPS beat(8)-10.29%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)13.4%
PT rev (3m)25.9%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)5.88%
EPS NY rev (3m)-15.81%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF 826.22
P/B 5.36
P/tB 5.36
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)-0.32
FCFYN/A
OCF(TTM)0.01
OCFY0.12%
SpS0
BVpS1.48
TBVpS1.48
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -1.34%
ROE -2.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.35%
ROA(5y)-9.46%
ROE(3y)-5.86%
ROE(5y)-11.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 163339%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.9
Quick Ratio 3.9
Altman-Z 5.96
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)68824.3%
Cap/Depr(5y)53394.6%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y-2%
EPS Next 2Y-135.05%
EPS Next 3Y-69.21%
EPS Next 5Y-44.84%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-39.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-120%
EBIT Next 3Y-30.84%
EBIT Next 5Y-3.01%
FCF growth 1Y-55.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y115.07%
OCF growth 3YN/A
OCF growth 5YN/A

ARIZONA SONORAN COPPER CO IN / ASCU.CA Fundamental Analysis FAQ

What is the fundamental rating for ASCU stock?

ChartMill assigns a fundamental rating of 2 / 10 to ASCU.CA.


What is the valuation status for ASCU stock?

ChartMill assigns a valuation rating of 0 / 10 to ARIZONA SONORAN COPPER CO IN (ASCU.CA). This can be considered as Overvalued.


What is the profitability of ASCU stock?

ARIZONA SONORAN COPPER CO IN (ASCU.CA) has a profitability rating of 2 / 10.


Can you provide the financial health for ASCU stock?

The financial health rating of ARIZONA SONORAN COPPER CO IN (ASCU.CA) is 5 / 10.